drugset / Trial / NCT03471169
Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease
Phase 1
Unknown
3500 enrolled
Xuanwu Hospital, Beijing
Chinese PLA General Hospital · collabPeking University People's Hospital · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
To investigate the therapeutic effect of individualized treatment of antiplatelet in secondary prevention of ischemic stroke.
Timeline
- Start
- 2017-04-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bayaspirin | Unknown | — | — |
| Subject | Cilostazol | Small molecule | — | — |
| Subject | Clopidogrel | Small molecule | — | — |